Erebouni Medical Center
Medical Journal Erebouni

Safety and efficacy of fixed dose combination of indapamide SR/Amlodipine in single- pill versus free dual therapy at the same dose over 12 – week of treatment, with conditional titration based on the blood pressure control, in patients with mild to moder


Report

DATE – 2011 -2013


Name of the specialist – Hayrapetyan G.G.


Role – Principal Investigator
– International multicenter open placebo – controlled research (protocol of the research CL3 – 055)

Jointly participating Organization – Servier Laboratories (France) (Gagik Velijanyan, www.servier.com/)


Result – the research is not finished yet


Publications – none yet

In accordance with the "Law of Copyright and Related Rights" when copying or reproduction of materials posted on this site, specify the source - the Web site of the Erebouni Medical Center - erebunimed.com is highly requested.
Back to top